HMO/HMOPOS · observed 2026 → 2026 · 75 months of CPSC history · 17 active CY 2026 plans.
| Plan | Category | Premium | MOOP | ★ | Counties | Enrollment |
|---|---|---|---|---|---|---|
| Aetna Medicare Full Dual Care (HMO D-SNP) H3312/069 · Dual-Eligible | SNP | $59 | $9,250 | 3.0 | 9 | 42,374 |
| Aetna Medicare Full Dual (HMO D-SNP) H3312/070 · Dual-Eligible | SNP | $23 | $9,250 | 3.0 | 45 | 16,268 |
| Aetna Medicare Signature Care (HMO) H3312/074 | MA-PD | $0 | $9,250 | 3.0 | 6 | 8,061 |
| Aetna Medicare Signature (HMO) H3312/002 | MA-PD | $0 | $9,250 | 3.0 | 2 | 7,574 |
| Aetna Medicare Signature (HMO) H3312/048 | MA-PD | $0 | $9,250 | 3.0 | 16 | 7,474 |
| Aetna Medicare Signature (HMO) H3312/062 | MA-PD | $0 | $9,250 | 3.0 | 16 | 5,987 |
| Aetna Medicare Chronic Care (HMO C-SNP) H3312/091 · Chronic or Disabling Condition | SNP | $0 | $9,250 | 3.0 | 5 | 4,792 |
| Aetna Medicare Signature (HMO-POS) H3312/065 | MA-PD | $0 | $6,750 | 3.0 | 5 | 3,810 |
| Aetna Medicare Partial Dual Care (HMO D-SNP) H3312/090 · Dual-Eligible | SNP | $38 | $9,250 | 3.0 | 9 | 1,727 |
| Aetna Medicare Enhanced (HMO) H3312/082 | MA-PD | $91 | $9,250 | 3.0 | 1 | 1,040 |
| Aetna Medicare Partial Dual (HMO D-SNP) H3312/089 · Dual-Eligible | SNP | $6 | $9,250 | 3.0 | 45 | 1,022 |
| Aetna Medicare Enhanced (HMO-POS) H3312/018 | MA-PD | $69 | $9,250 | 3.0 | 2 | 946 |
| Aetna Medicare Enhanced (HMO) H3312/064 | MA-PD | $94 | $9,250 | 3.0 | 2 | 608 |
| Aetna Medicare Full Dual (HMO D-SNP) H3312/087 · Dual-Eligible | SNP | $36 | $9,250 | 3.0 | 8 | 602 |
| Aetna Medicare Enhanced (HMO) H3312/081 | MA-PD | $74 | $9,250 | 3.0 | 1 | 245 |
| Aetna Medicare Signature (HMO) H3312/097 | MA-PD | $184 | $9,250 | 3.0 | 4 | 89 |
| Aetna Medicare FIDE Care (HMO D-SNP) H3312/073 · Dual-Eligible | SNP | $50 | $9,250 | 3.0 | 1 | 0 |
| ID | Measure | ★ |
|---|---|---|
| C01 | Breast Cancer Screening | 3.0 |
| C02 | Colorectal Cancer Screening | 3.0 |
| C03 | Annual Flu Vaccine | 2.0 |
| C04 | Improving or Maintaining Physical Health | 3.0 |
| C05 | Improving or Maintaining Mental Health | 3.0 |
| C06 | Monitoring Physical Activity | 3.0 |
| C07 | Special Needs Plan (SNP) Care Management | 3.0 |
| C08 | Care for Older Adults – Medication Review | 5.0 |
| C09 | Care for Older Adults – Pain Assessment | 4.0 |
| C10 | Osteoporosis Management in Women who had a Fracture | 3.0 |
| C11 | Diabetes Care – Eye Exam | 3.0 |
| C12 | Diabetes Care – Blood Sugar Controlled | 3.0 |
| C13 | Kidney Health Evaluation for Patients with Diabetes | 2.0 |
| C14 | Controlling High Blood Pressure | 4.0 |
| C15 | Reducing the Risk of Falling | 4.0 |
| C16 | Improving Bladder Control | 3.0 |
| C17 | Medication Reconciliation Post-Discharge | 5.0 |
| C18 | Plan All-Cause Readmissions | 4.0 |
| C19 | Statin Therapy for Patients with Cardiovascular Disease | 3.0 |
| C20 | Transitions of Care | 2.0 |
| C21 | Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions | 3.0 |
| C22 | Getting Needed Care | 2.0 |
| C23 | Getting Appointments and Care Quickly | 1.0 |
| C24 | Customer Service | 2.0 |
| C25 | Rating of Health Care Quality | 1.0 |
| C26 | Rating of Health Plan | 2.0 |
| C27 | Care Coordination | 3.0 |
| C28 | Complaints about the Health Plan | 4.0 |
| C29 | Members Choosing to Leave the Plan | 3.0 |
| C30 | Health Plan Quality Improvement | 2.0 |
| C31 | Plan Makes Timely Decisions about Appeals | 3.0 |
| C32 | Reviewing Appeals Decisions | 5.0 |
| C33 | Call Center – Foreign Language Interpreter and TTY Availability | 4.0 |
| D01 | Call Center – Foreign Language Interpreter and TTY Availability | 5.0 |
| D02 | Complaints about the Drug Plan | 4.0 |
| D03 | Members Choosing to Leave the Plan | 3.0 |
| D04 | Drug Plan Quality Improvement | 3.0 |
| D05 | Rating of Drug Plan | 2.0 |
| D06 | Getting Needed Prescription Drugs | 3.0 |
| D07 | MPF Price Accuracy | 5.0 |
| D08 | Medication Adherence for Diabetes Medications | 3.0 |
| D09 | Medication Adherence for Hypertension (RAS antagonists) | 3.0 |
| D10 | Medication Adherence for Cholesterol (Statins) | 2.0 |
| D11 | MTM Program Completion Rate for CMR | 5.0 |
| D12 | Statin Use in Persons with Diabetes (SUPD) | 3.0 |
No incoming transitions for this contract.